CRISPR-Cas13 as an Antiviral Strategy for Coronavirus Disease 2019
- PMID: 33560913
- DOI: 10.1089/crispr.2020.29094.yzh
CRISPR-Cas13 as an Antiviral Strategy for Coronavirus Disease 2019
Comment on
-
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.Cell. 2020 May 14;181(4):865-876.e12. doi: 10.1016/j.cell.2020.04.020. Epub 2020 Apr 29. Cell. 2020. PMID: 32353252 Free PMC article.
Similar articles
-
A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.Med Hypotheses. 2022 Feb;159:110754. doi: 10.1016/j.mehy.2021.110754. Epub 2022 Jan 4. Med Hypotheses. 2022. PMID: 35002020 Free PMC article.
-
CRISPR Tech Behind Super-Sensitive, Smartphone COVID Test.IEEE Pulse. 2021 Mar-Apr;12(2):8-11. doi: 10.1109/MPULS.2021.3066716. IEEE Pulse. 2021. PMID: 33877966 Free PMC article.
-
Comment on the article by Zaami S, et al. "CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19". Eur Rev Med Pharmacol Sci 2021; 25 (3): 1752-1761.Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):2830-2833. doi: 10.26355/eurrev_202104_25535. Eur Rev Med Pharmacol Sci. 2021. PMID: 33877687 No abstract available.
-
Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2.Curr Pharm Biotechnol. 2021;22(9):1149-1155. doi: 10.2174/1389201021666201009154517. Curr Pharm Biotechnol. 2021. PMID: 33038909 Review.
-
Of chloroquine and COVID-19.Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5. Antiviral Res. 2020. PMID: 32147496 Free PMC article. Review.
Cited by
-
Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.Int J Mol Sci. 2022 Sep 27;23(19):11400. doi: 10.3390/ijms231911400. Int J Mol Sci. 2022. PMID: 36232699 Free PMC article. Review.
-
CRISPR-Cas system: from diagnostic tool to potential antiviral treatment.Appl Microbiol Biotechnol. 2022 Sep;106(18):5863-5877. doi: 10.1007/s00253-022-12135-2. Epub 2022 Aug 26. Appl Microbiol Biotechnol. 2022. PMID: 36008567 Free PMC article. Review.
-
Engineering CRISPR/Cas13 System against RNA Viruses: From Diagnostics to Therapeutics.Bioengineering (Basel). 2022 Jun 29;9(7):291. doi: 10.3390/bioengineering9070291. Bioengineering (Basel). 2022. PMID: 35877342 Free PMC article. Review.
-
Methods for in vitro CRISPR/CasRx-Mediated RNA Editing.Front Cell Dev Biol. 2021 Jun 11;9:667879. doi: 10.3389/fcell.2021.667879. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34178991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical